Pages that link to "Q46109613"

The following pages link to Preventive and therapeutic effects of imatinib in Wistar-Kyoto rats with anti-glomerular basement membrane glomerulonephritis (Q46109613):

Displaying 20 items.

• What is new in the management of rapidly progressive glomerulonephritis? (Q28259540) (← links)
• Targeting the tyrosine kinase signalling pathways for treatment of immune-mediated glomerulonephritis: from bench to bedside and beyond (Q33620537) (← links)
• Therapeutic effects of human mesenchymal stem cells in Wistar-Kyoto rats with anti-glomerular basement membrane glomerulonephritis (Q34797271) (← links)
• Imatinib ameliorates renal morphological changes in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension (Q35652125) (← links)
• Weekly injections of Hylan G-F 20 delay cartilage degeneration in partial meniscectomized rat knees (Q36000348) (← links)
• The emergence of the glomerular parietal epithelial cell. (Q38182323) (← links)
• PDGF and the progression of renal disease. (Q38185014) (← links)
• Targeting CTGF, EGF and PDGF pathways to prevent progression of kidney disease. (Q38259755) (← links)
• A spleen tyrosine kinase inhibitor reduces the severity of established glomerulonephritis (Q39485380) (← links)
• Albumin-induced epithelial-mesenchymal transition and ER stress are regulated through a common ROS-c-Src kinase-mTOR pathway: effect of imatinib mesylate (Q39582921) (← links)
• Nilotinib Attenuates Renal Injury and Prolongs Survival in Chronic Kidney Disease (Q42015762) (← links)
• Long- and short-term treatment with imatinib attenuates the development of chronic kidney disease in experimental anti-glomerular basement membrane nephritis (Q44464485) (← links)
• A Novel Role of a Chemotherapeutic Agent in a Rat Model of Endotoxemia: Modulation of the STAT-3 Signaling Pathway (Q46573219) (← links)
• Meniscus regeneration by syngeneic, minor mismatched, and major mismatched transplantation of synovial mesenchymal stem cells in a rat model. (Q46917130) (← links)
• Erlotinib attenuates the progression of chronic kidney disease in rats with remnant kidney. (Q48636743) (← links)
• Therapeutic effects and mechanism of conditioned media from human mesenchymal stem cells on anti-GBM glomerulonephritis in WKY rats. (Q51387145) (← links)
• Selective pharmacological inhibition of DDR1 prevents experimentally-induced glomerulonephritis in prevention and therapeutic regime. (Q54977339) (← links)
• Early short-term imatinib treatment is sufficient to prevent the development of chronic allograft nephropathy (Q83341190) (← links)
• The effectiveness of chitosan-mediated silencing of PDGF-B and PDGFR-β in the mesangial proliferative glomerulonephritis therapy (Q91555360) (← links)
• Podocyte Injury in Lupus Nephritis (Q93016595) (← links)